Last updated: March 17, 2024
Sponsor: RenJi Hospital
Overall Status: Completed
Phase
N/A
Condition
Colon Cancer
Esophageal Cancer
Gastric Cancer
Treatment
Standard monitoring
Capnography monitoring
Clinical Study ID
NCT05030870
RenjiH-20201201
Ages 65-79 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- 65 ≤ Age <80
- patients undergoing gastrointestinal endoscopes
- patients signed informed consent form
- ASA classification I-II
Exclusion
Exclusion Criteria:
- Coagulation disorders or a tendency of nose bleeding
- An episode/exacerbation of congestive heart failure (CHF) that requires a change inmedication, diet or hospitalization from any cause in the last 6 months
- Severe aortic stenosis or mitral stenosis
- Cardiac surgery involving thoracotomy (e.g., coronary artery bypass graft (CABG),valve replacement surgery) in the last 6 months
- Acute myocardial infarction in the last 6 months
- Acute arrhythmia (including any tachycardia - or bradycardia) with the fluid ofhemodynamics instability
- Diagnosed chronic obstructive pulmonary disease or current other acute or chronic lungdisease requiring supplemental chronic or intermittent oxygen therapy)
- Pre-existing bradycardia (heart rate < 50 / min), or hypoxia (SaO2< 90 % )
- Need supplemental oxygen because of pre-existing diseases
- Emergency procedure or surgery
- Multiple trauma
- Upper respiratory tract infection
- Allergy to propofol or tape and adhesives
Study Design
Total Participants: 1800
Treatment Group(s): 2
Primary Treatment: Standard monitoring
Phase:
Study Start date:
September 01, 2021
Estimated Completion Date:
January 01, 2023
Connect with a study center
Henan Provincial People's Hospital
Zhenzhou, Henan 450003
ChinaSite Not Available
Qilu Hospital of Shandong University
Qingdao, Shandong 250012
ChinaSite Not Available
Renji Hospital
Shanghai, Shanghai 200127
ChinaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.